Universal WBC reduction and patient advocacy [5]

Transfusion

Volumn 40, Issue 12, 2000, Pages 1545-1546

  Goldfinger, Dennis ^a   Klapper, Ellen ^a   Pepkowitz, Samuel H ^b   Millar, Sanford I ^b   Heal, Joanna M ^c   Blumberg, Neil ^a,b   Wuest, David ^b   Reich, Lilian ^a   Mayer, Klaus ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CYTOMEGALOVIRUS; FEVER; FOOD AND DRUG ADMINISTRATION; HUMAN RIGHTS; LETTER; LEUKOCYTE; UNITED STATES; VIRUS TRANSMISSION;

BLOOD COMPONENT TRANSFUSION; HUMANS; LEUKOCYTES; PATIENT ADVOCACY;

EID: 0034520349     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40121545.x     Document Type: Letter

References (7)

1. Universal WBC reduction
2. Airbus has a lot riding on new jumbo as it seeks to jettison No. 1 Boeing
3. A critical analysis of saline washed red blood cells with special reference to their ability to prevent adverse reactions to blood transfusion
4. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell depleted stem cell transplantation
5. Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion: Report of a case and review of the literature
6. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Pro
7. Integrating the new generation of blood components into transfusion practice